» Articles » PMID: 29075285

Epigenetics in the Eye: An Overview of the Most Relevant Ocular Diseases

Overview
Journal Front Genet
Date 2017 Oct 28
PMID 29075285
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Sight for mammals is one of the most appreciated senses. In humans there are several factors that contribute to the increment in all kind of eye diseases. This mini-review will focus on some diseases whose prevalence is steadily increasing year after year for non-genetic reasons, namely cataracts, dry eye, and glaucoma. Aging, diet, inflammation, drugs, oxidative stress, seasonal and circadian style-of-live changes are impacting on disease prevalence by epigenetics factors, defined as stable heritable traits that are not explained by changes in DNA sequence. The mini-review will concisely show the data showing epigenetics marks in these diseases and on how knowledge on the epigenetic alterations may guide therapeutic approaches to have a healthy eye.

Citing Articles

Epigenetic Modulation Directs Recovery Post LASIK and SMILE Surgery: An Experimental Study.

Shetty R, Khamar P, Kannan R, Thacker P, Kumar N, Ghosh A Life (Basel). 2025; 15(2).

PMID: 40003656 PMC: 11856829. DOI: 10.3390/life15020246.


Identification of Wnt-5a Receptors Important in Diabetic and Non-Diabetic Corneal Epithelial Wound Healing.

Shah R, Amador C, Poe A, Spektor T, Bhandary P, Wang Y Invest Ophthalmol Vis Sci. 2025; 66(2):64.

PMID: 39998459 PMC: 11875028. DOI: 10.1167/iovs.66.2.64.


Role of epigenetics in corneal health and disease.

Sood S, Tiwari A, Sangwan J, Vohra M, Sinha N, Tripathi R Prog Retin Eye Res. 2024; 104():101318.

PMID: 39547455 PMC: 11710990. DOI: 10.1016/j.preteyeres.2024.101318.


Clinical management of eye diseases: carotenoids and their nanoformulations as choice of therapeutics.

Das A, Shahriar T, Zehravi M, Sweilam S, Alshehri M, Ahmad I Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(1):329-349.

PMID: 39167170 DOI: 10.1007/s00210-024-03376-1.


Epigenetics in Glaucoma.

DEsposito F, Gagliano C, Bloom P, Cordeiro M, Avitabile A, Gagliano G Medicina (Kaunas). 2024; 60(6).

PMID: 38929522 PMC: 11205742. DOI: 10.3390/medicina60060905.


References
1.
Wei L, Liu B, Tuo J, Shen D, Chen P, Li Z . Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. Cell Rep. 2012; 2(5):1151-8. PMC: 3513594. DOI: 10.1016/j.celrep.2012.10.013. View

2.
Marchese F, Huarte M . Long non-coding RNAs and chromatin modifiers: their place in the epigenetic code. Epigenetics. 2013; 9(1):21-6. PMC: 3928181. DOI: 10.4161/epi.27472. View

3.
Tay Y, Rinn J, Pandolfi P . The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505(7483):344-52. PMC: 4113481. DOI: 10.1038/nature12986. View

4.
Casson R, Chidlow G, Wood J, Crowston J, Goldberg I . Definition of glaucoma: clinical and experimental concepts. Clin Exp Ophthalmol. 2012; 40(4):341-9. DOI: 10.1111/j.1442-9071.2012.02773.x. View

5.
Romano G, Platania C, Drago F, Salomone S, Ragusa M, Barbagallo C . Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An Animal and Human Study. Front Pharmacol. 2017; 8:168. PMC: 5371655. DOI: 10.3389/fphar.2017.00168. View